Skip to main content

7 September 2026

Last updated: Thursday 3 September 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Bicycle Therapeutics developing highly specific and highly stable biopharmaceuticals

Wednesday 4 November 2009

Interviewee/Contributor

Regina Hodits

Organisation

Bicycle Therapeutics Ltd

Organisations

Celtic Pharmaceutical Holdings LP
TreeFrog Therapeutics SAS
Food and Drug Administration
Innovation & International Relationship
IsomAb Ltd
IP Group
Ysios Capital
Strategus
Synpromics Ltd
Max-Planck- Innovation GmbH

Interviewees and Contributers

Ted Bianco
Dr Konrad Glund
André Choulika
Lukas Heukamp
John Dean
Andy Smith
Stephen Megit
Alexa Machikas and Elena Kfoury
Björn Dahlöf
John Burt

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

EB Research Institute forms advisory board

Wednesday 2 September 2026

Redx Pharma changes board after financing close

Wednesday 2 September 2026

New CEO at Neumora Therapeutics

Wednesday 2 September 2026

New CEO at BICO

Wednesday 2 September 2026

OncoOne forms SAB

Sunday 30 August 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form